Commit Biologics Holding ApS: Financial statements 2024
CVR: 42604232
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
Commit Biologics Holding ApS (CVR 42604232) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -11,750 and a net result of DKK -14,948 compared with DKK -13,199 the year before. Equity in the 2024 report amounted to DKK -5,205.
- Gross Profit
- DKK -11,750
- Profit/Loss
- DKK -14,948
- Equity
- DKK -5,205
- Total Assets
- DKK 48,532
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | -12 t. | -15 t. | -5 t. | 0 |
| 2023 | - | -12 t. | -13 t. | 10 t. | 0 |
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
Commit Biologics Holding ApS has published its annual report for 2023. Gross profit came to DKK -11,563, and the net result was DKK -13,199.
About Commit Biologics Holding ApS
Commit Biologics Holding ApS is a Danish company of the type Anpartsselskab based in Auning, founded in 2021. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Nick Stub Laursen, Dennis Vestergaard Pedersen and Heidi Gytz Olesen. The company's owners include Nick Stub Laursen, Dennis Vestergaard Pedersen and Heidi Gytz Olesen. In 2025, the company reported a gross profit of DKK -10,093 and a net result of DKK -12,988 compared with DKK -14,948 the year before. Equity in the 2025 report amounted to DKK -18,193.